Sharon Bio-Medicine Ltd. announced audited standalone earnings results for the quarter and year ended March 31, 2019. For the quarter, the company reported revenue from operation was INR 401.263 million compared to INR 350.320 million a year ago. Total income was INR 409.258 million compared to INR 370.308 million a year ago. Profit for the period was INR 37.173 million or INR 0.32 per basic earnings per share compared to loss for the period of INR 67.469 million or INR 0.53 per basic loss per share a year ago. For the year, the company reported revenue from operation was INR 1,446.452 million compared to INR 1,286.543 million a year ago. Total income was INR 1,470.049 million compared to INR 1,307.638 million a year ago. Profit for the period was INR 112.617 million or INR 0.96 per basic earnings per share compared to loss for the period of INR 1,012.989 million or INR 8.49 per basic loss per share a year ago.